WO1995018620A1 - Treatment using arachidonic acid metabolite and particulate formulations - Google Patents

Treatment using arachidonic acid metabolite and particulate formulations Download PDF

Info

Publication number
WO1995018620A1
WO1995018620A1 PCT/US1995/000370 US9500370W WO9518620A1 WO 1995018620 A1 WO1995018620 A1 WO 1995018620A1 US 9500370 W US9500370 W US 9500370W WO 9518620 A1 WO9518620 A1 WO 9518620A1
Authority
WO
WIPO (PCT)
Prior art keywords
particle
disorder
endocytosable
metabolite
animal
Prior art date
Application number
PCT/US1995/000370
Other languages
English (en)
French (fr)
Inventor
Andrew S. Janoff
David F. Eierman
Original Assignee
The Liposome Company, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Liposome Company, Inc. filed Critical The Liposome Company, Inc.
Priority to AU16018/95A priority Critical patent/AU682753B2/en
Priority to JP7518686A priority patent/JPH10507737A/ja
Priority to EP95908028A priority patent/EP0738151A1/en
Publication of WO1995018620A1 publication Critical patent/WO1995018620A1/en
Priority to FI962806A priority patent/FI962806A/fi
Priority to NO962911A priority patent/NO962911L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PCT/US1995/000370 1994-01-11 1995-01-11 Treatment using arachidonic acid metabolite and particulate formulations WO1995018620A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU16018/95A AU682753B2 (en) 1994-01-11 1995-01-11 Treatment using arachidonic acid metabolite and particulate formulations
JP7518686A JPH10507737A (ja) 1994-01-11 1995-01-11 アラキドン酸代謝産物および粒子製剤を用いる治療
EP95908028A EP0738151A1 (en) 1994-01-11 1995-01-11 Treatment using arachidonic acid metabolite and particulate formulations
FI962806A FI962806A (fi) 1994-01-11 1996-07-10 Käsittely, jossa käytetään arakidonhappometaboliitin ja hiukkasen muodostamia formulaatioita
NO962911A NO962911L (no) 1994-01-11 1996-07-10 Behandling ved anvendelse av arachidonsyremetabolit og partikkelformige formuleringer

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17973994A 1994-01-11 1994-01-11
US08/179,739 1994-01-11
US20334194A 1994-02-28 1994-02-28
US08/203,341 1994-02-28

Publications (1)

Publication Number Publication Date
WO1995018620A1 true WO1995018620A1 (en) 1995-07-13

Family

ID=26875610

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1995/000370 WO1995018620A1 (en) 1994-01-11 1995-01-11 Treatment using arachidonic acid metabolite and particulate formulations

Country Status (7)

Country Link
EP (1) EP0738151A1 (ja)
JP (1) JPH10507737A (ja)
AU (1) AU682753B2 (ja)
CA (1) CA2179986A1 (ja)
FI (1) FI962806A (ja)
NO (1) NO962911L (ja)
WO (1) WO1995018620A1 (ja)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0512916A2 (en) * 1991-05-07 1992-11-11 The Liposome Company, Inc. Liposomal prostaglandin formulations
WO1993002681A1 (de) * 1991-07-31 1993-02-18 Knoll Aktiengesellschaft Prostaglandin e1-formulierung

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0512916A2 (en) * 1991-05-07 1992-11-11 The Liposome Company, Inc. Liposomal prostaglandin formulations
WO1993002681A1 (de) * 1991-07-31 1993-02-18 Knoll Aktiengesellschaft Prostaglandin e1-formulierung

Also Published As

Publication number Publication date
AU682753B2 (en) 1997-10-16
JPH10507737A (ja) 1998-07-28
FI962806A0 (fi) 1996-07-10
CA2179986A1 (en) 1995-07-13
NO962911L (no) 1996-09-03
EP0738151A1 (en) 1996-10-23
FI962806A (fi) 1996-09-10
NO962911D0 (no) 1996-07-10
AU1601895A (en) 1995-08-01

Similar Documents

Publication Publication Date Title
US5925375A (en) Therapeutic use of multilamellar liposomal prostaglandin formulations
US4755388A (en) Liposome-encapsulated 5-fluoropyrimidines and methods for their use
KR970005171B1 (ko) 아라키돈산 대사물질 관련 리포좀 제조방법 및 그 제제
US6660525B2 (en) Therapeutic liposome composition and method
US4844904A (en) Liposome composition
EP0726764B1 (en) Multilamellar liposomal arachidonic acid metabolite formulations
US5811118A (en) Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
US5840328A (en) Treatment using arachidonic acid metabolite and particulate formulations
AU682753B2 (en) Treatment using arachidonic acid metabolite and particulate formulations
US5882678A (en) Interdigitation-fusion liposomes containing arachidonic acid metabolites
US20070071805A1 (en) Treatment of inflammation and vascular abnormalities of the eye
EP0729352B1 (en) Interdigitation-fusion liposomes containing arachidonic acid metabolites
JP2634047B2 (ja) アルファトコフェロールをベースとした小胞体
WO1991006310A1 (en) Liposomal compositions
JPH1160491A (ja) アムホテリシンｂ含有製剤

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA FI JP KR NO

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2179986

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 962806

Country of ref document: FI

WWE Wipo information: entry into national phase

Ref document number: 1995908028

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1995908028

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: 1995908028

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1995908028

Country of ref document: EP